维普中文期刊产品整合服务
20篇 您的检索式:作者名="Armakolas"
    题名 作者 年代 出处 被引量
1IGF1Ec expres- sion in MG-63 human osteoblast like osteosarcoma cells显示文摘Philippou A Armakolas A Panteleakou Z 2011Anticaneer Res2011,31,12:1
2Insulinlike growthfactor-1Ec(MGF)expression in eutopic and ectopic endometrium:characterization of the MGF E-peptide actions in vitro显示文摘Milingos DS Philippou A Armakolas A 2011MolMed2011,17,12:1
3Insulinlike growth factor-1 Ec(MGF)exprevssion in eutopic and ectopic endometrium:characterization of the MGF E-peptide actions in vitro显示文摘MIUNGOS D S PHILIPPOU A ARMAKOLAS A 2011Mol Med2011,17,12:1
4Preferential expression of IGF-1 Ec(MGF)transcript in cancerous tissues of human prostate:evidence for a novel and autonomous growth factor activity of MGF E peptide in human prostate cancer cells显示文摘ARMAKOLAS A PHILIPPOU A PANTELEAKOU Z 2010Prostate2010,70,11:1
5Gastric emptying after semi–solid food in multiple system atrophy and Parkinson disease显示文摘T. Thomaides T. Karapanayiotides Y. Zoukos C. Haeropoulos E. Kerezoudi N. Demacopoulos G. Floodas E. Papageorgiou F. Armakola Y. Thomopoulos I. Zaloni 2005Journal of Neurology2005,,9:1
6Prognostic significance of circulating antibodies against carcinoembryonic antigen (anti-CEA) in patients with colon cancer显示文摘Albanopoulos K Armakolas A Konstadoulakis MM Leandros E Tsiompanou E Katsaragakis S Alexiou D Androulakis G 0,,04:1
7IGF1Ec expression in MG-63 human osteoblast-like osteosarcoma ceils 显示文摘Philippou A Armakolas A Panteleakou Z 2011Antieancer Res2011,31,12:1
8Detection of the cir- culating tumor cells in cancer patients显示文摘Armakolas A Panteleakou Z Nezos A 2010Future Oncol2010,6,12:1
9Detection of the circulating tumor cells in cancer patients 显示文摘Armakolas A Panteleakou Z Nezos A 2010Future Oncol2010,6,12:1
10Prognostic significance of circulating antibodies against carcinoembryonic antigen(anti-CEA) in patients with colon cancer显示文摘Albanopoulos K Armakolas A Konstadoulakis MM 2000Am J Gastroentrerol2000,95,4:1
11Granulocyte colony-stimulating factor expression as a prognostic biomarker in non-small cell lung cancer显示文摘Stathopoulos GP Armakolas A Tranga T 2011Oncol Rep2011,25,6:1
12Detection of the circulating tumor cells in cancer patients 显示文摘Armakolas A Panteleakou Z Nezos A 2010Future Oncol2010,6,12:1
13Inhibition of RNAlariat debranching enzyme suppresses TDP-43 toxicity in ALSdisease models显示文摘Armakola M Higgins MJ Figley MD 2012Nat Genet2012,44,:1
14Prognostic significance of circulating antibodies against carcinoembryonic antigen (anti-CEA) in patients with colon cancer显示文摘Albanopoulos K Armakolas A Konstadoulakis MM 2000Am J Gastroenterol2000,95,4:1
15Granulocyte col- ony-stimulating factor expression as a prognostic biomarker in non- small cell lung cancer显示文摘Stathopoulos G P Armakolas A Tranga T 2011Oncol Rep2011,25,6:1
16Prognosis significance of circulating antibodies againstcarcinoembryonic antigen(anti-CEA)in patients withcolon cancer显示文摘Albanopoulos K Armakolas A Konstadoulakism M etal 2000Am J gastroenterol2000,95,4:1
17Prognosis significance of circulating antibodies against carcinoembryonic antigen ( anti - CEA ) in patients with colon cancer显示文摘ALBANOPOULOS K ARMAKOLAS A KONSTADOULAKIS M M 2000Am J gastroenterol2000,95,4:1
18Granulocyte colony-stimulating factor expression as a prognostic biomarker in non-small cell lung cancer显示文摘Stathopoulos GP Armakolas A Tranga T 2011OncolRep2011,25,6:1
19Expression of the insulin-like growth factor 1 ( IGF-l ) and type I IGF receptor mRNAs in human HLE- B3 lensepithelial cells 显示文摘Moschos MM Armakolas A Philippou A Pissimissis N Pante- leakou Z Nezos A 2011In Vivo2011,25,2:1
20Ariadne’s Thread in the Network of Hepatocellular Carcinoma Immunobiology显示文摘Hepatocellular carcinoma(HCC)accounts for approximately 90%of primary liver cancers and represents a major global health problem.The main risk factors responsible for the development of HCC are chronic viral infections,non-alcoholic fatty liver disease,and alcohol-related liver disease,with wide geographical distribution.1 HCC development and growth involve multiple factors and pathways that lead to changes in gene expression,immune interactions and changes in the tumor microenvironment.In recent years,much progress has been made in understanding the mechanisms underlying tumor-immune system interactions and immunotherapy has been successfully applied to many tumors.Moreover,cancer-specific immune prognostic signatures have been evaluated in order to predict prognosis and response.John Koskinas Athanasios Armakolas 2021Journal of Clinical and Translational Hepatology2021,9,3:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费